Roble Belko & Company’s Amgen AMGN Stock Holding History

Roble Belko & Company’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4K	Hold	12	–	–	﹤0.01%	361
2026 Q1	$4K	Sell	12 -242	-95%	-$86.3K	﹤0.01%	354
2025 Q4	$83K	Buy	254 +242	+2,017%	+$76.8K	0.01%	180
2025 Q3	$3K	Buy	+12	New	+$3.48K	﹤0.01%	334
2018 Q1	–	Sell	-437	Closed	-$76K	–	329
2017 Q4	$76K	Hold	437	–	–	0.03%	91
2017 Q3	$81K	Hold	437	–	–	0.04%	79
2017 Q2	$75K	Hold	437	–	–	0.04%	84
2017 Q1	$72K	Hold	437	–	–	0.04%	85
2016 Q4	$64K	Sell	437 -94	-18%	-$14.1K	0.03%	90
2016 Q3	$89K	Buy	531 +131	+33%	+$22.2K	0.05%	81
2016 Q2	$61K	Hold	400	–	–	0.03%	100
2016 Q1	$60K	Hold	400	–	–	0.03%	90
2015 Q4	$65K	Buy	+400	New	+$62.9K	0.04%	82

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Roble Belko & Company's AMGN Position: Q2 2026 in Review

Roble Belko & Company held its Amgen (AMGN) position steady in Q2 2026 at 12 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #361.

Roble Belko & Company first reported a position in AMGN in Q4 2015 and has held it in 13 quarters since. The position peaked at $89K in Q3 2016. 1,227 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Roble Belko & Company held 12 shares of Amgen worth $4K as of Q2 2026.
Roble Belko & Company left its Amgen share count unchanged in Q2 2026.
Amgen made up ﹤0.01% of Roble Belko & Company's portfolio in Q2 2026, its #361 holding.
Roble Belko & Company first reported a position in Amgen in Q4 2015 and has held it in 13 quarters since.
Roble Belko & Company's Amgen position peaked at $89K in Q3 2016.
1,227 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.